← Back to bills and search results
2025 · Regular session · House bill
HB2516
The Chris Larkin ALS Act requires an issuer that offers Medicare supplement coverage to people 65 and older to offer the same coverage to people under 65 who are eligible for and enrolled in Medicare because of end-stage renal di…
Official caption: Relating to the eligibility of certain individuals younger than 65 years of age to purchase Medicare supplement benefit plans.
Official report lists House author(s): Guillen, Dean, Wharton, Johnson, Buckley. This does not identify sponsors or amendment drafters.
Bill explanation published · Version and amendment review scope is stated below · Individual amendment records may not be separately annotated.
Bill highlights
Selected points from the published explanation. Follow each point to its source-linked context; conditions and limits may matter.
- The Chris Larkin ALS Act requires an issuer that offers Medicare supplement coverage to people 65 and older to offer the same coverage to people under 65 who are eligible for and enrolled in Medicare because of end-stage renal disease or amyotrophic lateral sclerosis (ALS).
- The law sets two pricing rules.
- An eligible person has a six-month enrollment period beginning on the first day of the first month they become enrolled in Medicare Part B.
- For people already under 65 and enrolled in Part B because of ALS or end-stage renal disease on June 20, 2025, the act also created a transitional application window, stated as “after December 1, 2025, and before June 1, 2026.” If a person requested an application during that period but could not apply because the application was unavailable, the statute instead allows six months from when the application first becomes available.
- The act became effective immediately on June 20, 2025, but its changes apply to supplement plans delivered, issued for delivery or renewed on or after September 1, 2025.
What does it do?
The Chris Larkin ALS Act requires an issuer that offers Medicare supplement coverage to people 65 and older to offer the same coverage to people under 65 who are eligible for and enrolled in Medicare because of end-stage renal disease or amyotrophic lateral sclerosis (ALS). The final law does not extend this particular new protection to every person under 65 who qualifies for Medicare because of another disability. It concerns Medicare supplement insurance, often called Medigap, not a new state payment of Medicare premiums. Final law, Sections 1–2.
The law sets two pricing rules. Standardized Medigap Plans A, B and D must be offered at the same premium rate charged to a 65-year-old. Other offered Medigap plans may cost no more than 200% of the rate charged to a 65-year-old for the same plan—twice that rate, not three times it. These Medigap plan letters are not Medicare Parts A, B and D. The act does not require an insurer to introduce every standardized plan or make coverage free. Final law, new Insurance Code 1652.059.
An eligible person has a six-month enrollment period beginning on the first day of the first month they become enrolled in Medicare Part B. During the protected enrollment period, the issuer cannot deny or condition issuance of an available plan, use medical underwriting or health-based price discrimination, impose a waiting period, or limit or exclude benefits because of a preexisting condition. The commissioner must adopt implementing rules, including rules designating enrollment periods. The protection is not a statement that every application at any time must be accepted. Final law, new Insurance Code 1652.060.
For people already under 65 and enrolled in Part B because of ALS or end-stage renal disease on June 20, 2025, the act also created a transitional application window, stated as “after December 1, 2025, and before June 1, 2026.” If a person requested an application during that period but could not apply because the application was unavailable, the statute instead allows six months from when the application first becomes available. The ordinary transitional window is now past; this is not a promise that it remains open indefinitely. The delayed-application provision and other applicable enrollment periods must be considered separately. Final law, Section 4.
The act became effective immediately on June 20, 2025, but its changes apply to supplement plans delivered, issued for delivery or renewed on or after September 1, 2025. In its implementation bulletin, the Texas Department of Insurance said carriers need not automatically change existing enrollees’ rates without a new application and encouraged notification of the new opportunity. The bulletin’s shorthand should not replace the enacted premium ceiling or exact statutory dates quoted above. Final law, Sections 3–5; official history; TDI implementation bulletin.
What changed along the way?
The introduced bill covered disability or end-stage renal disease, required all offered plans at the age-65 rate, and included a proposed annual 60-day birthday enrollment period. The House substitute expressly added ALS, changed the pricing rule to age-65 parity for Plans A/B/D and a twice-age-65 cap for other plans, removed the proposed annual birthday window, and expressly prohibited waiting periods and preexisting-condition limitations during protected enrollment. The final act does not enact the proposed annual birthday window. Introduced bill; House substitute.
House Amendment 1, adopted, added the Chris Larkin name and the immediate-effect voting clause. Senate Amendment F1, adopted, narrowed eligibility to ALS only by removing disability and end-stage renal disease. Senate Amendment F2, also adopted, moved the transitional window from the proposed August 31, 2025/March 2, 2026 boundaries to the final December 1, 2025/June 1, 2026 boundaries. House amendment; Senate F1; Senate F2; amendment index.
The House rejected the Senate changes and requested a conference committee. The final compromise restored end-stage renal disease alongside ALS, but did not restore general disability eligibility. It retained the Senate’s later transitional dates. Both chambers adopted the conference report June 1, and its operative text matches the enrolled law. Thus neither the broader House bill nor the ALS-only Senate amendment is the final eligibility rule. Conference report and side-by-side comparison; final law; version index; history.
For the full amendment record, open the official amendment index.
Official bill versions
Compare the published text versions in the official text index. A change is not attributed to a specific amendment here without a verified record.
Who could benefit—and who could bear the costs?
Qualifying people with ALS or end-stage renal disease gain access and price protections that can make supplement insurance easier to obtain before age 65. They still owe premiums and remain subject to the plan’s covered benefits and ordinary requirements not displaced by the act. Insurers face additional enrollment, pricing and administrative obligations. The law does not quantify each family’s savings, insurer claims costs or effects on other customers’ premiums. Final law.
The Legislative Budget Board’s May 31, 2025 conference fiscal note, also posted with the final version, anticipates no significant state or local fiscal implication and assumes state costs can be absorbed with existing resources. The four earlier fiscal-note versions reached the same public-budget conclusion. That is not a finding that insurance coverage costs nothing or that private premiums cannot change. Conference fiscal note; final-posted note; introduced note; House-substitute note; engrossed note; second-house note.
Official sources
- Bill history and latest recorded action
- Bill versions, analyses and fiscal notes
- Action history and votes
- Amendment index
Catalog report retrieved 2026-10-25. Check the official record for corrections or later changes.